Targeting KRAS with Mutant Selective Monoclonal Antibodies

Time: 12:25 pm
day: Day Two

Details:

  • Generation of mutant selective monoclonal antibodies
  • Functional characterization of antibodies
  • Anti-tumor activity in a xenograft tumor model

Speakers: